The rise of Viagra initially sparked a boom for pharma, nevertheless recent developments present a murky outlook for shareholders. Generic alternatives are reducing profits, and continued litigation add more complexity https://frasertucr544937.glifeblog.com/39825361/sildenafil-and-big-pharma-a-volatile-investment